Cargando…

Initial experience with the subcutaneous implantable cardioverter-defibrillator with the real costs of hospitalization analysis in a single Polish center

BACKGROUND: The recent introduction of an entirely subcutaneous implantable cardioverter-defibrillator (S-ICD) represents an important progress in the defibrillation technology towards a less invasive approach. This is a single-center observational study of S-ICD implantations in Poland. METHODS: Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grabowski, Marcin, Gawałko, Monika, Michalak, Marcin, Cacko, Andrzej, Kowara, Michał, Kołodzińska, Agnieszka, Januszkiewicz, Łukasz, Balsam, Paweł, Serdoz, Laura Vitali, Winter, Joachim, Opolski, Grzegorz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Via Medica 2019
Materias:	Clinical Cardiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084361/ https://www.ncbi.nlm.nih.gov/pubmed/29611175 http://dx.doi.org/10.5603/CJ.a2018.0024

Ejemplares similares

Multicentre early experience with totally subcutaneous cardioverter-defibrillators in Poland
por: Kaczmarek, Krzysztof, et al.
Publicado: (2019)

The role of hemostatic markers as venous stenosis or occlusion predictors following first transvenous cardiac device implantation
por: Cacko, Andrzej, et al.
Publicado: (2019)

Predictors of venous stenosis or occlusion following first transvenous cardiac device implantation: Prospective observational study
por: Cacko, Andrzej, et al.
Publicado: (2018)

Subcutaneous Implantable Cardioverter-Defibrillator Lead Dislodgement Masquerading as Left Shoulder Pain
por: Chirumamilla, Yashitha, et al.
Publicado: (2023)

An Apple Watch a day keeps the doctor away?
por: Basza, Mikołaj, et al.
Publicado: (2021)

Comparative effectiveness of torasemide versus furosemide in symptomatic therapy in heart failure patients: Preliminary results from the randomized TORNADO trial
por: Balsam, Paweł, et al.
Publicado: (2020)

The subcutaneous implantable cardioverter-defibrillator: A tertiary center experience
por: Khazen, Cesar, et al.
Publicado: (2019)

Inappropriate Shocks With Subcutaneous Implantable Cardioverter-Defibrillator in a Young Patient: A Case Report
por: Khan, Zahid, et al.
Publicado: (2023)

Subcutaneous Implantable Cardioverter Defibrillators for the Prevention of Sudden Cardiac Death: Pediatric Single-Center Experience
por: Wieniawski, Piotr, et al.
Publicado: (2022)

Effects and Complications of Subcutaneous Implantable Cardioverter-Defibrillator in the Prevention of Sudden Cardiac Death: A Narrative Review
por: Pagore, Prasad A, et al.
Publicado: (2022)

Inappropriate Subcutaneous Implantable Cardioverter Defibrillator Shocks Secondary to Cardiac Remodeling: A Unique Case of T Wave Oversensing
por: Saleem, Maleeha, et al.
Publicado: (2022)

A survey study of the use of a subcutaneous implantable cardioverter-defibrillator in various clinical scenarios by expert electrophysiologists in Poland
por: Kempa, Maciej, et al.
Publicado: (2023)

Inappropriate Shock from Subcutaneous Implantable Cardioverter-Defibrillator Caused by Electrical Remodeling After Wolff-Parkinson-White Ablation
por: Mohammadi, Oranus, et al.
Publicado: (2020)

Stenotrophomonas maltophilia Endocarditis of an Implantable Cardioverter Defibrillator Lead
por: Satish, Mohan, et al.
Publicado: (2019)

Automated Implantable Cardioverter Defibrillator/Pacemaker Lead Fracture
por: Rubero, Jose, et al.
Publicado: (2020)

An interactive assistant for patients with cardiac implantable electronic devices: A study protocol of the LUCY trial
por: Michalik, Joanna, et al.
Publicado: (2018)

Novel biochemical predictors of unfavorable prognosis for stable coronary disease
por: Cacko, Andrzej, et al.
Publicado: (2018)

Success rate and safety of catheter ablation in preexcitation syndrome: A comparison between adult and pediatric patients
por: Pietrzak, Radosław, et al.
Publicado: (2022)

Administrative Data in Cardiovascular Research—A Comparison of Polish National Health Fund and CRAFT Registry Data
por: Maciejewski, Cezary, et al.
Publicado: (2022)

A Challenging Case of Electrical Storm in an Implantable Cardioverter Defibrillator Patient
por: Elkhouly, Ahmed, et al.
Publicado: (2020)

Actual status and future directions of cardiac telerehabilitation
por: Milewski, Krzysztof, et al.
Publicado: (2023)

Hyperkalemia Causing Inappropriate Subcutaneous Implantable Cardioverter Defibrillator Shocks in a Patient with End-Stage Renal Disease: A Case Report and Literature Review
por: Botrus, Bachar, et al.
Publicado: (2022)

Utilization of Subcutaneous Cardioverter-Defibrillator in Poland and Europe–Comparison of the Results of Multi-Center Registries
por: Kempa, Maciej, et al.
Publicado: (2021)

OCULUS study: Virtual reality-based education in daily clinical practice
por: Balsam, Paweł, et al.
Publicado: (2019)

Kardia Mobile applicability in clinical practice: A comparison of Kardia Mobile and standard 12-lead electrocardiogram records in 100 consecutive patients of a tertiary cardiovascular care center
por: Koltowski, Lukasz, et al.
Publicado: (2021)

Appropriateness of Prescription and Safety of Wearable Cardioverter Defibrillators: A Single-center Experience
por: Sundhu, Murtaza, et al.
Publicado: (2019)

The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
por: Nair, Krishnakumar, et al.
Publicado: (2014)

Brugada Syndrome: The Role of Risk Stratification in Selecting Patients for Implantable Cardioverter-defibrillator Placement
por: Mankbadi, Michael, et al.
Publicado: (2018)

The Role of the Automated Implantable Cardioverter Defibrillator (AICD) for Secondary Prevention in the COVID-19 Era
por: Doodnauth, Andrew V, et al.
Publicado: (2021)

Refractory Vasospastic Angina and Sudden Cardiac Arrest: Is Implantable Cardioverter Defibrillator Indicated and Is It Always Protective?
por: Riaz, Sana, et al.
Publicado: (2020)

Giant Left Main Coronary Artery Aneurysm Presenting as Multiple Implantable Cardioverter Defibrillator Shocks
por: Malyshev, Yury, et al.
Publicado: (2020)

Predictors of Elevated Defibrillation Threshold with the Subcutaneous Implantable Cardioverter-defibrillator
por: Do, Khuyen, et al.
Publicado: (2017)

Patients with Cardiovascular Implantable Electronic Devices in the Era of COVID-19 and Their Response to Telemedical Solutions
por: Paskudzka, Diana, et al.
Publicado: (2022)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Reel Syndrome: An Atypical Cause for Inappropriate Shocks in a Patient with Automated Implantable Cardioverter Defibrillator (AICD)
por: Mohammad, Rabia, et al.
Publicado: (2018)

A Case of 25 Inappropriate Automatic Implantable Cardioverter Defibrillator Shocks and 22 Episodes of Antitachycardia Pacing
por: Morrison, Nathan, et al.
Publicado: (2023)

Subcutaneous Implantable Cardioverter Defibrillator: Early Experience
por: Souza, Fernando Sérgio Oliva, et al.
Publicado: (2017)

Comparative outcomes of subcutaneous and transvenous cardioverter-defibrillators
por: Liang, Jin-Jun, et al.
Publicado: (2019)

A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of immunosuppression in biopsy-proven virus-negative myocarditis or inflammatory cardiomyopathy (IMPROVE-MC)
por: Ozierański, Krzysztof, et al.
Publicado: (2022)

High-Risk Apical Hypertrophic Cardiomyopathy Requiring an Implantable Cardioverter-Defibrillator: A Case Report of an Overlooked Etiology
por: Rathore, Azeem, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_iaagl0lcpk5qgdntnfufgckngc